GG 367 (Benazepril hydrochloride and hydrochlorothiazide 20 mg / 25 mg)

Pill imprint GG 367 has been identified as Benazepril hydrochloride and hydrochlorothiazide 20 mg / 25 mg.

Benazepril is used in the treatment of high blood pressure; diabetic kidney disease; left ventricular dysfunction; heart failure and belongs to the drug class angiotensin converting enzyme inhibitors. There is positive evidence of human fetal risk during pregnancy. Benazepril 20 mg / 25 mg is not subject to the Controlled Substances Act.

See also related documents.

Images for GG 367 (Benazepril hydrochloride and hydrochlorothiazide 20 mg / 25 mg)

Benazepril hydrochloride and hydrochlorothiazide 20 mg / 25 mg GG 367
Benazepril hydrochloride and hydrochlorothiazide
Imprint:
GG 367
Strength:
20 mg / 25 mg
Color:
Red
Shape:
Elliptical / Oval
Availability:
Prescription only
Drug Class:
Angiotensin converting enzyme inhibitors
Pregnancy Category:
D - Positive evidence of risk
CSA Schedule:
N - Not a controlled drug
Manufacturer:
Sandoz Pharmaceuticals Inc.
National Drug Code (NDC):
00781-5134
Other Manufacturers / Repackagers:
NDC CodeManufacturer / Repackager
33358-0050 Core Pharmaceuticals Inc (repackager)

Note: Inactive ingredients may vary.

View Details Print Page

Pill Identifier

Search by Imprint, Shape or Color

Note: All fields are optional. Use the pill finder to identify medications by visual appearance or name. All Rx and OTC drugs in the US are required by the FDA to have an imprint. If your pill has no imprint it could be a vitamin, diet/herbal/energy pill, illicit or foreign drug. More about imprint codes...

Search by Drug Name

Search by National Drug Codes (NDC)

Questions about Atrial Fibrillation? Get answers from our expert. Watch Video

Close
Hide
(web5)